Showing results (321-330 of 390) with videos related to
Sort By:
Pageof 39
Cancer Immunology Research|June 21, 2019
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal CancerCarino Gurjao, David Liu, Matan Hofree, et al.Nature Cancer|February 5, 2022
Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncologyBrendan Reardon, Nathanael D Moore, Nicholas S Moore, et al.The Journal of Thoracic and Cardiovascular Surgery|January 25, 2026
Randomized, Sham-Controlled Trial of Intraoperative Ticagrelor Removal to Reduce Perioperative BleedingMichael J Mack, Richard Whitlock, Michael W A Chu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2019
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent LymphomaJohn P Leonard, Marek Trneny, Koji Izutsu, et al.Cold Spring Harbor Molecular Case Studies|March 17, 2017
An exome sequencing study of Moebius syndrome including atypical cases reveals an individual with CFEOM3A and a TUBB3 mutationRonak M Patel, David Liu, Claudia Gonzaga-Jauregui, et al.BMC Health Services Research|December 29, 2022
Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics in the same health systemsPaige D Wartko, Hongxiang Qiu, Abisola E Idu, et al.Lancet (London, England)|November 19, 2017
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trialJoshua D Lee, Edward V Nunes, Patricia Novo, et al.Cell Reports|June 24, 2026
Recurrent ZC3H18 mutations stabilize oncogenic endogenous retroviral RNATanzina Tanu, Anna M Cox, Jennifer A Karlow, et al.Nature Communications|April 7, 2022
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogrammingZhaowei Chu, Lei Gu, Yeguang Hu, et al.Biorxiv : the Preprint Server for Biology|May 7, 2024
Specific oncogene activation of the cell of origin in mucosal melanomaSwathy Babu, Jiajia Chen, Emily Robitschek, et al.Pageof 39